Diabetes Drug Leads To, Significant Weight Loss
in Those With Obesity, Study Finds.
Researchers with Yale University recently published the results of their study in the
'New England Journal of Medicine.'.
The diabetes drug tirzepatide was the focus of the study, which also included calorie restriction and 150 minutes of weekly exercise.
Nearly 95 percent of the participants were classified as obese when the study began.
91 percent of the participants who were given the highest dose of the drug lost
five percent or more of their body weight.
We should treat obesity as we treat any chronic disease – , Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
... with effective and safe approaches which target underlying disease mechanisms – , Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
... and these results underscore that tirzepatide may be doing
just that, Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
Weight loss is about improving a person’s health. , Professor Rachel Batterham, University College London, via 'The Guardian'.
If you want to improve the really difficult complications of obesity, then you need 15-20%
weight loss, Professor Rachel Batterham, University College London, via 'The Guardian'.
Experts warn that "this class of drugs only works providing the participants stick to the reduced calorie diet prescribed with the drug.".
So it is not a magic bullet, Tom Sanders, King’s College London,
via 'The Guardian'.
Experts also say that "improving the food environment would have the biggest impact of all so should remain a focus for the government.”.
The emergence of these new drugs does not mean people should ditch lifestyles as it is far better to prevent obesity in the first place, Professor Naveed Sattar, University of Glasgow, via 'The Guardian'
in Those With Obesity, Study Finds.
Researchers with Yale University recently published the results of their study in the
'New England Journal of Medicine.'.
The diabetes drug tirzepatide was the focus of the study, which also included calorie restriction and 150 minutes of weekly exercise.
Nearly 95 percent of the participants were classified as obese when the study began.
91 percent of the participants who were given the highest dose of the drug lost
five percent or more of their body weight.
We should treat obesity as we treat any chronic disease – , Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
... with effective and safe approaches which target underlying disease mechanisms – , Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
... and these results underscore that tirzepatide may be doing
just that, Dr. Ania Jastreboff, Yale University and
Lead Author, via 'The Guardian'.
Weight loss is about improving a person’s health. , Professor Rachel Batterham, University College London, via 'The Guardian'.
If you want to improve the really difficult complications of obesity, then you need 15-20%
weight loss, Professor Rachel Batterham, University College London, via 'The Guardian'.
Experts warn that "this class of drugs only works providing the participants stick to the reduced calorie diet prescribed with the drug.".
So it is not a magic bullet, Tom Sanders, King’s College London,
via 'The Guardian'.
Experts also say that "improving the food environment would have the biggest impact of all so should remain a focus for the government.”.
The emergence of these new drugs does not mean people should ditch lifestyles as it is far better to prevent obesity in the first place, Professor Naveed Sattar, University of Glasgow, via 'The Guardian'
Category
🗞
News